HIV / AIDS in the News

4th Circuit rules against discharged service members with HIV - Washington Blade

 

4th Circ. Backs Military Policy Banning HIV-Positive Enlistees - Law360

 

4th Circ. Backs Military Policy Banning HIV-Positive Enlistees - Law360

 

Exposing a hidden anchor for HIV replication - Phys.org

 

GSK's HIV Treatment Achieves Superior Results in Phase III Trial - GuruFocus

 

Georgia bill would allow pharmacists to prescribe PrEP in effort to expand HIV prevention access - CBS News

 

Fourth Circuit defers to military on policy disqualifying HIV-positive applicants - Courthouse News

 

Fourth Circuit defers to military on policy disqualifying HIV-positive applicants - Courthouse News

 

Pentagon can ban recruits living with HIV, conservative court rules - The Independent

 

Pentagon can ban recruits living with HIV, conservative court rules - the-independent.com

 

ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM - Yahoo Finance

 

Monthly HIV shots outperform daily pills for people with adherence challenges - Stock Titan

 

ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM - Business Wire

 

HIV assistance cuts: Is the DeSantis administration ‘kneecapping’ Legislature? - Florida Phoenix

 

Fourth Circuit Reinstates Military’s HIV Ban - Lambda Legal

 

ViiV Healthcare to share pipeline and real-world data at CROI 2026 - Managed Healthcare Executive

 

US military's ban on enlistment by people with HIV upheld by appeals court - Reuters

 

US military's ban on enlistment by people with HIV upheld by appeals court - TradingView

 

Military Can Enforce Policy Banning HIV-Positive Enlistees, 4th Circuit Rules - Law.com

 

Revealing a Concealed Key to HIV Replication - Bioengineer.org

 

Gilead Sciences to Present New HIV Treatment and Prevention Data at CROI 2026 - National Today

 

ViiV Healthcare Presents Ultra Long-Acting HIV Treatment and Prevention Data at CROI 2026 in Denver - Infection Control Today

 

Editorial: Money for HIV/AIDS is drying up - Bay Area Reporter

 

UBS raises Gilead Sciences stock price target on HIV pipeline data - Investing.com

 

Study reveals previously unknown role for viral protein integrase in HIV's life cycle - News-Medical

 

Integrase anchors viral RNA to the HIV-1 capsid interior - Nature

 

Virus-like particle vaccine has expanded rare HIV-targeting B cells in lab studies - Labmate-Online.com

 

Exposing a hidden anchor for HIV replication - EurekAlert!

 

Single Immunization Produces Broad HIV Neutralization in Preclinical Model, Pointing to Simpler Vaccine Strategies - Ragon Institute

 

Exposing a hidden anchor for HIV replication - University of Delaware